PMID- 20938213
OWN - NLM
STAT- MEDLINE
DCOM- 20110624
LR  - 20110317
IS  - 1423-0267 (Electronic)
IS  - 0030-3755 (Linking)
VI  - 225
IP  - 3
DP  - 2011
TI  - Retinal vein occlusion: current treatment.
PG  - 135-43
LID - 10.1159/000314718 [doi]
AB  - Retinal vein occlusion (RVO) is a pathology noted for more than 150 years. 
      Although a lot has been written on the matter, it is still a frequent condition 
      with multifactorial etiopathogenesis with many unclear aspects. The RVO 
      pathogenesis has varied systemic and local implications that make it difficult to 
      elaborate treatment guidelines. The management of the patient with RVO is very 
      complex and a multidisciplinary approach is required in order to identify and 
      correct the associated risk factors. Laser therapy remains the gold standard in 
      RVO, but only modest functional improvement has been shown in branch retinal 
      occlusion forms. Multicenter studies of intravitreal drugs present them as an 
      option to combine with laser. Anti-vascular endothelial growth factor, 
      corticosteroids and sustained-release implants are the future weapons to stop 
      disease progression and get a better visual outcome. Consequently, it is useful 
      to clarify some aspects of the pathology that allow a better patient management.
CI  - Copyright (c) 2010 S. Karger AG, Basel.
FAU - Lattanzio, Rosangela
AU  - Lattanzio R
AD  - Department of Ophthalmology, University Vita-Salute, Scientific Institute San 
      Raffaele, Milan, Italy.
FAU - Torres Gimeno, Ana
AU  - Torres Gimeno A
FAU - Battaglia Parodi, Maurizio
AU  - Battaglia Parodi M
FAU - Bandello, Francesco
AU  - Bandello F
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20100408
PL  - Switzerland
TA  - Ophthalmologica
JT  - Ophthalmologica. Journal international d'ophtalmologie. International journal of 
      ophthalmology. Zeitschrift fur Augenheilkunde
JID - 0054655
RN  - 0 (Angiogenesis Inhibitors)
RN  - 0 (Glucocorticoids)
SB  - IM
MH  - Angiogenesis Inhibitors/therapeutic use
MH  - Combined Modality Therapy
MH  - Glucocorticoids/therapeutic use
MH  - Humans
MH  - Intravitreal Injections
MH  - Laser Coagulation
MH  - Retinal Vein Occlusion/drug therapy/etiology/surgery/*therapy
EDAT- 2010/10/13 06:00
MHDA- 2011/06/28 06:00
CRDT- 2010/10/13 06:00
PHST- 2010/10/13 06:00 [entrez]
PHST- 2010/10/13 06:00 [pubmed]
PHST- 2011/06/28 06:00 [medline]
AID - 000314718 [pii]
AID - 10.1159/000314718 [doi]
PST - ppublish
SO  - Ophthalmologica. 2011;225(3):135-43. doi: 10.1159/000314718. Epub 2010 Apr 8.